Belem Avila, Ph.D.
Affiliations: | 2012 | Chemistry | University of California, Davis, Davis, CA |
Area:
Combinatorial chemistry, heterocyclic chemistry, understanding reaction mechanisms, solid phase organic synthesis, polymer chemistry, organic synthesis, reaction methodology, and structure elucidationGoogle:
"Belem Avila"Mean distance: 8.92 | S | N | B | C | P |
Parents
Sign in to add mentorMark Joseph Kurth | grad student | 2012 | UC Davis | |
(Three-Staged Inhibitors, Pyrazole-Based Heterocycles, and Benzothiazoles: Design, Synthesis, and Biological Evaluation of Unique Compounds.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Koltun DO, Parkhill EQ, Elzein E, et al. (2016) Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine. Bioorganic & Medicinal Chemistry Letters |
Avila B, El-Dakdouki MH, Nazer MZ, et al. (2012) Acid and base catalyzed Davis-Beirut reaction: experimental and theoretical mechanistic studies and synthesis of novel 3-amino-2H-indazoles. Tetrahedron Letters. 53: 6475-6478 |
Avila B, Roth A, Streets H, et al. (2012) Triazolbenzo[d]thiazoles: efficient synthesis and biological evaluation as neuroprotective agents. Bioorganic & Medicinal Chemistry Letters. 22: 5976-8 |
Avila B, Solano DM, Haddadin MJ, et al. (2011) Facile syntheses of novel benzo-1,3-dioxolo-, benzothiazolo-, pyrido-, and quinolino-fused 5H-benzo[d]-pyrazolo[5,1-b][1,3]-oxazines and 1H-pyrazoles. Organic Letters. 13: 1060-3 |
Avila B, Solano DM, Haddadin MJ, et al. (2011) ChemInform Abstract: Facile Syntheses of Novel Benzo-1,3-dioxolo-, Benzothiazolo-, Pyrido-, and Quinolino-Fused 5H-Benzo[d]pyrazolo[5,1-b][1,3]-oxazines and 1H-Pyrazoles. Cheminform. 42: no-no |
Ziebart KT, Dixon SM, Avila B, et al. (2010) Targeting multiple chorismate-utilizing enzymes with a single inhibitor: validation of a three-stage design. Journal of Medicinal Chemistry. 53: 3718-29 |